[1]陆秉文,胥静,谢立科,等.青蒿琥酯对大鼠实验性视网膜分支静脉阻塞的抑制作用[J].眼科新进展,2022,42(11):853-857.[doi:10.13389/j.cnki.rao.2022.0176]
　LU Bingwen,XU Jing,XIE Like,et al.Inhibitory effect of artesunate on experimental branch retinal vein occlusion in rats[J].Recent Advances in Ophthalmology,2022,42(11):853-857.[doi:10.13389/j.cnki.rao.2022.0176]
点击复制

青蒿琥酯对大鼠实验性视网膜分支静脉阻塞的抑制作用/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
42卷
期数:
2022年11期
页码:
853-857
栏目:
实验研究
出版日期:
2022-11-05

文章信息/Info

Title:
Inhibitory effect of artesunate on experimental branch retinal vein occlusion in rats
作者:
陆秉文; 胥静; 谢立科; 杨强
100040　北京市，中国中医科学院眼科医院（陆秉文，胥静，谢立科）；110164　辽宁省沈阳市，沈阳兴齐眼药股份有限公司（杨强）
Author(s):
LU Bingwen1; XU Jing1; XIE Like1; YANG Qiang2
1.Department of Ophthalmology,Eye Hospital,China Academy of Chinese Medical Sciences,Beijing 100040,China
2.Shenyang Sinqi Ophthalmic Medicine Co.Ltd.,Shenyang 110024,Liaoning Province,China
关键词:
青蒿琥酯; 视网膜分支静脉阻塞; HIF-1α/VEGF信号通路; 大鼠
Keywords:
artesunate;  branch retinal vein occlusion;  hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway;  rats
分类号:
R774
DOI:
10.13389/j.cnki.rao.2022.0176
文献标志码:
A
摘要:
目的　探讨青蒿琥酯（Art）对大鼠实验性视网膜分支静脉阻塞（BRVO）的抑制作用。方法　取SPF级雌性Wistar大鼠150只，将动物随机分为6组，每组25只，右眼为实验眼：空白对照组、模型对照组（玻璃体内注射生理盐水）、康柏西普组、Art高浓度（50.0 mg·L-1）组、Art中浓度（25.0 mg·L-1）组、Art低浓度（12.5 mg·L-1）组；空白对照组采用未造模大鼠进行实验，其他各组采用BRVO模型大鼠进行实验。采用光化学法建立大鼠BRVO模型。模型建立后行玻璃体内注射给药，注药后1 d、3 d、7 d及14 d行眼底照相观察血管阻塞、视网膜水肿情况；行HE染色观察视网膜组织形态，并测量视网膜内层厚度；实时荧光定量PCR检测视网膜组织VEGF、HIF-1α mRNA表达情况。结果　玻璃体内注药后1 d，模型对照组，康柏西普组，Art高、中、低浓度组大鼠出现视网膜静脉阻塞、迂曲扩张及视网膜出血水肿表现。玻璃体内注药后7 d，康柏西普组和Art高、中、低浓度组大鼠视网膜静脉再通，仅有小部分静脉血管阻塞；而康柏西普组和Art高、中、低浓度大鼠视网膜静脉阻塞表现差异不明显。玻璃体内注药后7 d，模型对照组大鼠视网膜组织水肿，其中神经纤维层与内丛状层水肿明显，视网膜神经节细胞可见空泡样变性。康柏西普组和Art高、中、低浓度组大鼠视网膜水肿基本消失，视网膜神经节细胞空泡变性明显改善。玻璃体内注药后3 d、7 d、14 d，康柏西普组，Art高、中、低浓度组大鼠视网膜内层厚度明显小于模型对照组（均为P<0.05）。玻璃体内注药后1 d、3 d，模型对照组大鼠视网膜组织HIF-1α mRNA相对表达量较空白对照组均升高（均为P<0.05）；注药后7 d， HIF-1α mRNA相对表达量则降低（P<0.05）。注药后1 d、3 d，康柏西普组，Art高、中、低浓度组大鼠视网膜组织HIF-1α mRNA相对表达量较模型对照组均降低（均为P<0.05）。玻璃体内注药后7 d、14 d，模型对照组大鼠视网膜组织VEGF mRNA的相对表达量较空白对照组均升高（均为P<0.05）；康柏西普组，Art高、中、低浓度组VEGF mRNA的相对表达量较模型对照组均降低（均为P<0.05）。结论　Art可以减轻BRVO大鼠视网膜损伤程度，其机制可能与调控HIF-1α/VEGF信号通路有关。
Abstract:
Objective　To investigate the inhibitory effect of artesunate (Art) on experimental branch retinal vein occlusion (BRVO) in rats. Methods　A total of 150 healthy SPF female Wistar rats (with the right eye being the experimental eye) were selected and randomly divided into six groups: blank control group, model control group (intravitreal injection of normal saline), Conbercept group, Art high concentration group (50.0 mg·L-1), Art medium concentration group (25.0 mg·L-1), and Art low concentration group (12.5 mg·L-1), with 25 rats in each group. Rats in the blank control group were not modeled, while rats in the other groups were modeled with BRVO by laser photocoagulation and intravitreally injected with different drugs. On the 1st, 3rd, 7th, and 14th days after intervention, vascular occlusion and retinal edema were observed by fundus photography, the morphology of the retinal tissue was evaluated and the thickness of the retinal inner layer was measured by hematoxylin-eosin staining, and the mRNA expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α) was determined by quantitative real-time polymerase chain reaction. Results　One day after intravitreal injection, rats in the model control group, Conbercept group, and Art high, medium and low concentration groups showed retinal vein occlusion, tortuosity and dilatation, and retinal hemorrhage and edema. On the 7th day after intravitreal injection, the retinal veins of rats in the Conbercept group and the Art high, medium and low concentration groups were recanalized, except that a small part of the veins was still obstructed. There was no significant difference in retinal vein occlusion between the Conbercept group and the Art high, medium and low concentration groups. On the 7th day after intravitreal injection, the retinal tissue, especially the nerve fiber layer and the inner plexiform layer of rats in the model control group, showed edema, and vacuolar degeneration was observed in retinal ganglion cells; the retinal edema of rats in the Conbercept group and the Art high, medium and low concentration groups almost disappeared, and the vacuolar degeneration in retinal ganglion cells significantly improved. On the 3rd, 7th and 14th days after intravitreal injection, the thickness of the retinal inner layer in the Conbercept group and the Art high, medium and low concentration groups significantly reduced when compared with the model control group (all P<0.05). On the 1st and 3rd days after intravitreal injection, the expression of HIF-1α mRNA in the model control group significantly increased when compared with the blank control group (both P<0.05), while decreased on the 7th day after intravitreal injection (P<0.05). On the 1st and 3rd days after intravitreal injection, the expression of HIF-1α mRNA in the Conbercept group and the Art high, medium and low concentration groups remarkably reduced when compared with the model control group (both P<0.05). On the 7th and 14th days after intravitreal injection, the expression of VEGF mRNA in the model control group was higher than that in the blank control group (both P<0.05), while the expression of VEGF mRNA in the Conbercept group and the Art high, medium and low concentration groups was lower than that in the model control group (all P<0.05). Conclusion　Art can effectively alleviate retinal injury in BRVO rats, which may be related to its regulation of the HIF-1α/VEGF signaling pathway.

参考文献/References:

［1］　IP M,HENDRICK A.Retinal vein occlusion review［J］.Asia Pac J Ophthalmol (Phila),2018,7(1):40-45.
［2］　HOGG H,TALKS S J,PEARCE M,DI SIMPLICIO S.Real-World visual and neovascularisation outcomes from anti-VEGF in central retinal vein occlusion［J］.Ophthalmic Epidemiol,2021,28(1):70-76.
［3］　LU B W,BAUM L,SO K F,CHIU K,XIE L K.More than anti-malarial agents:therapeutic potential of artemisinins in neurodegeneration［J］.Neural Regen Res,2019,14(9):1494-1498.
［4］　ZONG Y,YUAN Y,QIAN X,HUANG Z,YANG W,LIN L,et al.Small Molecular-Sized artesunate attenuates ocular neovascularization via VEGFR2,PKCα,and PDGFR targets［J］.Sci Rep,2016,6:30843.
［5］　WANG N,CHEN H,TENG Y,DING X,WU H,JIN X.Artesunate inhibits proliferation and invasion of mouse hemangioendothelioma cells in vitro and of tumor growth in vivo［J］.Oncol Lett,2017,14(5):6170-6176.
［6］　陆秉文,孙中轻,吴改萍,赵健,熊国吟,谢立科.青蒿琥酯治疗视网膜静脉阻塞继发黄斑水肿作用探讨［J］.中国中医眼科杂志,2021,31(10):748-753.
LU B W,SUN Z Q,WU G P,ZHAO J,XIONG G Y,XIE L K.The effect of artesunate in the treatment of macular edema secondary to retinal vein occlusion［J］.CHN J Chin Ophthalmol,2021,10(31):748-753.
［7］　邹红,黎蕾,缪晚虹.光动力疗法建立大鼠视网膜静脉阻塞模型［J］.中国激光医学杂志,2013,22(6):303-307,354-355.
ZOU H,LI L,MIAO W H.Photodynamic development of experimental retinal vein occlusion of rats ［J］.Chin J Laser Med Surg,2013,6(22):303-307,354-355.
［8］　LI C,FENG X,WEN X,LI Y,LIU B,HU J,et al.A pilot clinical study of intravitreal injection of artesunate for ocular neovascularization［J］.J Ocul Pharmacol Ther,2019,35(5):283-290.
［9］　LU B W,XIE L K.Potential applications of artemisinins in ocular diseases［J］.Int J Ophthalmol,2019,12(11):1793-1800.
［10］　孙梅,郝晓凤,谢立科,金琪,王诗惠,胥静.视网膜静脉阻塞动物模型的制作方法［J］.国际眼科杂志,2020,20(11):1841-1846.
SUN M,HAO X F,XIE L K,JIN Q,WANG S H,XU J.Methods for making animal models of retinal vein occlusion ［J］.Int Eye Sci,2020,11(20):1841-1846.

相似文献/References:

[1]张祺 冯劼 李培凤 金翼.Lucentis联合氪黄激光治疗视网膜分支静脉阻塞黄斑水肿的疗效观察[J].眼科新进展,2013,33(12):000.
[2]曹婷婷,陈桂芬,范玉香,等.视网膜分支静脉阻塞合并黄斑水肿不同治疗方法的疗效观察[J].眼科新进展,2014,34(8):772.[doi:10.13389/j.cnki.rao.2014.0213]
　CAO Ting-Ting,CHEN Gui-Fen,FAN Yu-Xiang,et al.Clinical observation in different treatment methods of branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2014,34(11):772.[doi:10.13389/j.cnki.rao.2014.0213]
[3]傅维娜,陈梅珠,王云鹏. Lucentis联合视网膜光凝治疗视网膜分支静脉阻塞继发黄斑水肿[J].眼科新进展,2015,35(3):270.[doi:10.13389/j.cnki.rao.2015.0072]
　FU Wei-Na,CHEN Mei-Zhu,WANG Yun-Peng. Intravitreal injection with lucentis combined with local retinal photocoagulation for macular edema secondary to branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2015,35(11):270.[doi:10.13389/j.cnki.rao.2015.0072]
[4]董宁,汤欣,肖林,等. 视网膜分支静脉阻塞患者急性期和恢复期血浆同型半胱氨酸水平的变化[J].眼科新进展,2015,35(4):368.[doi:10.13389/j.cnki.rao.2015.0099]
　DONG Ning,TANG Xin,XIAO Lin,et al. Acute and convalescent changes in plasma homocysteine concentrations in branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2015,35(11):368.[doi:10.13389/j.cnki.rao.2015.0099]
[5]李仕永,高瑞莹,陈晖.雷珠单抗联合氩激光视网膜光凝治疗不同时期的视网膜分支静脉阻塞所致黄斑水肿的疗效[J].眼科新进展,2016,36(12):1161.[doi:10.13389/j.cnki.rao.2016.0309]
　LI Shi-Yong,GAO Rui-Ying,CHEN Hui.Effects of ranibizumab ( Lucentis) intravitreal injection combined with retinal argon laser photocoagulation on macular edema secondary to different period of branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(11):1161.[doi:10.13389/j.cnki.rao.2016.0309]
[6]王维宏,贺圣光,邓爱军,等.EDI-OCT在视网膜分支静脉阻塞患者筛板厚度测量中的应用[J].眼科新进展,2017,37(5):435.[doi:10.13389/j.cnki.rao.2017.0110]
　WANG Wei-Hong,HE Sheng-Guang,DENG Ai-Jun,et al.Application of EDI-OCT in measuring the plate thickness in patients with branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2017,37(11):435.[doi:10.13389/j.cnki.rao.2017.0110]
[7]陈静,陈艺,邹秀兰,等.青蒿琥酯对人Tenon囊成纤维细胞增殖与凋亡的影响[J].眼科新进展,2017,37(6):523.[doi:10.13389/j.cnki.rao.2017.0132]
　CHEN Jing,CHEN Yi,ZOU Xiu-Lan,et al.Effects of artesunate on cell proliferation and apoptosis of human Tenon’s capsule fibroblasts[J].Recent Advances in Ophthalmology,2017,37(11):523.[doi:10.13389/j.cnki.rao.2017.0132]
[8]胡一骏,李冬莉,李国栋,等.视网膜静脉阻塞的危险因素分析[J].眼科新进展,2017,37(6):544.[doi:10.13389/j.cnki.rao.2017.0137]
　HU Yi-Jun,LI Dong-Li,LI Guo-Dong,et al.Risk factors associated with retinal vein occlusion[J].Recent Advances in Ophthalmology,2017,37(11):544.[doi:10.13389/j.cnki.rao.2017.0137]
[9]刘广峰,洪婷婷,苗森,等.玻璃体内注射康柏西普与黄斑区光凝治疗视网膜分支静脉阻塞继发非缺血性黄斑水肿的临床对照研究[J].眼科新进展,2017,37(7):658.[doi:10.13389/j.cnki.rao.2017.0167]
　LIU Guang-Feng,HONG Ting-Ting,MIAO Sen,et al.Comparison of intravitreal injection of conbercept and macular photocoagulation for non-ischemic macular edema secondary to branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2017,37(11):658.[doi:10.13389/j.cnki.rao.2017.0167]
[10]石蕊,肖云芳,王峰,等.糖尿病合并视网膜分支静脉阻塞患者继发黄斑水肿后视力损伤程度及危险因素[J].眼科新进展,2017,37(12):1139.[doi:10.13389/j.cnki.rao.2017.0287]
　SHI Rui,XIAO Yun-Fang,WANG Feng,et al.Vision impairment following macular edema secondary to diabetes combined with branch retinal vein occlusion and its potential risk factors[J].Recent Advances in Ophthalmology,2017,37(11):1139.[doi:10.13389/j.cnki.rao.2017.0287]

备注/Memo

备注/Memo:
国家自然科学基金面上项目（编号：82174445）；北京市自然科学基金项目（编号：7192235）；北京中医药科技发展资金项目（编号：JJ2018-95）
更新日期/Last Update: 2022-11-05